Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial

Brent A. Neuschwander-Tetri, Rohit Loomba, Arun J. Sanyal, Joel E. Lavine, Mark L. Van Natta, Manal F. Abdelmalek, Naga Chalasani, Srinivasan Dasarathy, Anna Mae Diehl, Bilal Hameed, Kris V. Kowdley, Arthur McCullough, Norah Terrault, Jeanne M. Clark, James Tonascia, Elizabeth M. Brunt, David E. Kleiner, Edward Doo

Research output: Contribution to journal › Article › peer-review

1393 Scopus citations

Fingerprint

Dive into the research topics of 'Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences